United States: OIG Opines On Subsidizing Medicare Cost-Sharing For Clinical Trials - Foley & Lardner

In a recent Advisory Opinion No. 23-11 (Advisory Opinion), the Office of Inspector General (OIG) opined that it will not impose administrative sanctions against a clinical trial sponsor...